Skip to main content
Premium Trial:

Request an Annual Quote

Station X Wraps Up $5M Financing Round

NEW YORK (GenomeWeb News) – Station X, a Redwood City, Calif.-based bioinformatics firm, has closed a second round of equity financing led by Runa Capital that included follow-on commitments from existing investors including Genomic Health.

The company said this week that it plans to use the $5 million raised in this round to expand its team and to push forward commercialization plans for GenePool, its software for storing, analyzing, and visualizing genomic data in translational research settings, diagnostic and pharmaceutical development, and clinical genome analysis.

With this financing, Runa Capital's Andre Bliznyuk will join Station X's board of directors, which also includes the company's Co-founders Richard Goold and Tod Klingler; Randall Scott, a co-founder of Genomic Health and Incyte Genomics; and Roy Whitfield, a director at Illumina.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.